Bellicum Pharmaceuticals, Inc.
Q2 2020 13F Holders
Symbol
BLCM
CUSIP
079481404
Type
Equity
Class
COM NEW
Num filings
31
Total reported value, excl. options
$7.52 M
Compare 2020 Q2 to
2023 Q4
2023 Q2
2023 Q1
2022 Q4
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q1
Manager
Report Date
Value ($000)
Shares
Option Type